Skip to main content

Table 1 Parameters evaluating the completeness of the TMT labeling reaction at 0.5 mg, 0.25 mg, and 0.1 mg per 50 µL CSF sample

From: Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers

Amount TMT/50 µL CSF [mg]

Labeling efficiency [%]

Median peptide CV [%]

Median protein CV [%]

Median log2(MRII)

0.5

91.42

43.9

36.9

16.2

0.25

87.93

47.5

36.1

14.5

0.1

79.98

45.5

34.6

15.7